2017 - IXA


This page contains exclusive content for the member of the following sections: TTS, IXA. Log in to view.

yperimmunized/iABO Pre-Meeting Symposium - Hyperimmunized Patients

9.8 - New Agents for the Prevention and Treatment of AMR

Presenter: Stanley, Jordan, West Hollywood, United States
Authors:

New Agents for the Prevention and Treatment of AMR Stanley Jordan, Director, Nephrology & Transplant Immunology, Medical Director, Kidney Transplant Program, Kidney Transplant, Cedars Sinai , West Hollywood, CA, United States

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Address

International Xenotransplantation Association
C/O The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada